 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Bigmar, Inc.
 |
Bigmar, Inc. |
 |
 |
 |
PROFILE |
 |
Bigmar, through Swiss subsidiaries, makes generic oncology pharmaceuticals and intravenous solutions. Subsidiary Bigmar Pharmaceuticals manufactures various generic oncological drugs, which are sold in Brazil, Germany, Greece, Italy, Switzerland, Spain, and the US; marketing of the products is outsourced. Bioren makes and sells more than 20 intravenous infusion solutions directly to health care providers in Switzerland, such as hospitals, clinics, and retirement homes. Bioren is looking to capitalize on its experience with the Swiss marketplace by launching its own line of oncological pharmaceuticals.
COMPETITION |
 |
Bristol-Myers Squibb Company (BMY)
Pharmacia Corporation (PHA)
SICOR Inc. (SCRI)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 7.70
1-Yr. Sales Growth: (0.6)%
Employees: 94
Revenue per employee: $81,914.89
KEY PEOPLE |
 |
John G. Tramontana
CEO
Philippe J. H. Rohrer
CFO
CONTACT INFO |
 |
9711 Sportsman Club Rd.
Johnstown, OH 43031
US
Phone: 740-966-5800
Fax: 740-966-5801
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |